Daily non-political popular news in brief.
Novel drug preventing protein recycling shows potential for treating leukemia
04-19-2007 · EurekAlert!Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.
Read more »
Keywords: novel, drug, preventing, protein, recycling, shows, potential, treating, leukemia, show
« Previous | Next »
Similar news on "Novel drug preventing protein recycling shows potential for treating leukemia":
- 'Modular' leukemia drug shows promise in early testing
06-28-2007 · EurekAlert!
A new type of engineered drug candidate has shown promise in treating chronic lymphocytic leukemia in both test tube and early animal tests, a new study shows. The agent represents a new class of agents called small modular immunopharmaceuticals. Called CD37-SMIP, the agent targets a protein called CD37 on the surface of these leukemia cells.
Similar news · Read more »
- Novel MS drug shows promise in 2 lethal leukemias
08-28-2007 · EurekAlert!
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
Similar news · Read more »
- Study shows drug effective in treating, preventing breast cancer
11-01-2007 · EurekAlert!
A new study of an estrogen-derived drug shows promise as a treatment for breast cancer and breast cancer metastases to bone.
Similar news · Read more »
- Drug blocks lethal motor-neuron disease in mice
02-22-2007 · EurekAlert!
Spinal muscular atrophy (SMA) is a motor-neuron disease caused by mutations in the gene SMN1 that prevent it producing the protein SMN. New research shows that in a lethal mouse model of SMA the drug trichostatin A (TSA), which is a hydroxamic acid HDAC inhibitor, can improve survival and attenuate disease, indicating that hydroxamic acid HDAC inhibitors might be potential therapeutics for the treatment of individuals with SMA.
Similar news · Read more »
- Knocking out survival protein could aid leukemia treatment
04-20-2007 · EurekAlert!
An effective way to fight leukemia might be to knock out a specific protein that protects cancer cells from dying, a new study shows. The findings suggest that a drug that can block this "survival protein" might on its own be an effective therapy.
Similar news · Read more »
- Potential New Target For Leukemia Treatment
10-10-2006 · ScienceDaily
Cincinnati Children's Hospital Medical Center researchers have identified the crucial role and novel mechanism of action of the protein RhoH GTPase in the development and activation of cells critical to the immune system. The findings suggest that RhoH GTPase may provide a target for therapeutic intervention in some types of leukemia. The paper is due to appear in an upcoming edition of the journal, Nature Immunology.
Similar news · Read more »
- Researchers identify protein pathway involved in Parkinson disease development
06-18-2007 · EurekAlert!
Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. These new findings show how the mutations affect cellular function and could provide a target for drug therapies to treat the disease.
Similar news · Read more »
- Transdermal vaccine effective in treating Alzheimer's disease in mouse model
01-22-2007 · EurekAlert!
A novel needle-free vaccine approach was found safe and effective in clearing brain-damaging plaques from mice bred to develop Alzheimer's disease. The transdermal vaccination may offer a simple, noninvasive way of preventing or treating Alzheimer'swith less potential for adverse immune reactions.
Similar news · Read more »
- Weill Cornell team identifies potential new cancer drug target
06-21-2007 · EurekAlert!
Research led by scientists at Weill Cornell Medical College has uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP. Drugs that target either of these activities could help push cancer cells back into a more regular programmed cell death and thereby reduce or eliminate tumors.
Similar news · Read more »
- Discovery may pave the way for a new class of diabetes drugs
08-29-2007 · EurekAlert!
A multidisciplinary team led by researchers at the University of California, San Diego has determined the structure of a protein found in cells that shows potential as a target for the development of new drugs to treat diabetes.
Similar news · Read more »
